SYNPR
Synaptoporin
Also known as: MGC26651, SPO, SYNPR_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8TBG9
- Gene
- SYNPR
- Ensembl
- ENSG00000163630
- Chromosome
- 3
- Canonical length
- 265 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Vesicles,Cytosol
OverviewNCBI Gene
Predicted to be involved in modulation of chemical synaptic transmission. Predicted to be located in membrane; neuron projection; and synaptic vesicle. Predicted to be active in hippocampal mossy fiber to CA3 synapse and synaptic vesicle membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
265 residues, UniProt reviewed canonical sequence.
>Q8TBG9|SYNPR
1 MCMVIFAPLF AIFAFATCGG YSGGLRLSVD CVNKTESNLS IDIAFAYPFR LHQVTFEVPT
61 CEGKERQKLA LIGDSSSSAE FFVTVAVFAF LYSLAATVVY IFFQNKYREN NRGPLIDFIV
121 TVVFSFLWLV GSSAWAKGLS DVKVATDPKE VLLLMSACKQ PSNKCMAIHS PVMSSLNTSV
181 VFGFLNFILW AGNIWFVFKE TGWHSSGQRY LSDPMEKHSS SYNQGGYNQD SYGSSSGYSQ
241 QASLGPTSDE FGQQPTGPTS FTNQILocalizationUniProt · AlphaFold · HPA
Whether an antibody against SYNPR can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 4
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 262 nTPM
Expression across tissuesHPA
Tissue
- basal ganglia: 262 nTPM
- cerebellum: 106 nTPM
- cerebral cortex: 58 nTPM
- hippocampal formation: 57 nTPM
- amygdala: 49 nTPM
- hypothalamus: 36 nTPM
Single-cell type
- retinal amacrine cells: 872 nCPM
- retinal horizontal cells: 831 nCPM
- brain inhibitory neurons: 724 nCPM
- brain excitatory neurons: 434 nCPM
- pituitary stem cells: 191 nCPM
- other brain neurons: 126 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 253 nTPM
- basal ganglia: 188 nTPM
- cerebellum: 103 nTPM
- hippocampal formation: 82 nTPM
- thalamus: 81 nTPM
- white matter: 79 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.88
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.42
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SYNPR in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SYNPR as an antibody target. Whether an autoantibody or antibody against SYNPR could matter depends on whether native SYNPR is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SYNPR is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SYNPR as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...